Upper Respiratory Tract Infection
Efanesoctocog alfa offers ‘highly efficacious protection’ to children with hemophilia A
Efanesoctocog alfa prophylaxis exhibited high sustained factor VIII activity among younger children with severe hemophilia, according to findings published in The New England Journal of Medicine.
Antibody boosts platelets, shows ‘rapid and sustained efficacy’ in immune thrombocytopenia
Treatment with the novel antibody CM313 boosted platelet levels and demonstrated long-term durability among adults with immune thrombocytopenia, results from a phase 2 study showed.
Shorter primary care visits linked to greater likelihood of inappropriate prescribing
Shorter primary care visits were associated with an increased likelihood of inappropriate antibiotic prescribing and coprescribing opioids and benzodiazepines, a recent study found.
Physically active children less likely to get upper respiratory tract infections
Preschool children who had high daily step counts and played sports had less days with symptoms of upper respiratory tract infections than kids with less daily steps and no sport involvement, according to a study in Pediatric Research.
Waiting room intervention lowers patients' expectations about antibiotics
An intervention that was administered just before patients visited their family practitioner significantly reduced their expectations about receiving antibiotics for an upper respiratory tract infection, trial data show.
This Week's Headlines: May 17, 2021
This week, a monoclonal antibody cocktail cut COVID-19 hospitalization and death; removing race correction in lung function tests shows more severe disease in Black patients; gefapixant reduces chronic cough frequency in a large pooled analysis; and more.
Honey may be more effective than usual care for URTI symptoms
Honey may be more effective than usual care for symptoms of upper respiratory tract infection, or URTI, according to research published in BMJ Evidence-Based Medicine.
FDA OKs treatment for rare mutation of Duchenne muscular dystrophy
The FDA announced that it has granted accelerated approval for viltolarsen, an injection to treat Duchenne muscular dystrophy in those with a confirmed mutation.
Stewardship in the pediatrician’s office: Diagnostic certainty in acute otitis media
Diagnoses of acute otitis media or suppurative middle ear infection relies chiefly on examination findings of the tympanic membrane. In 2013, the AAP revised its initial 2004 guidelines to include stringent diagnostic criteria and emphasized the need for accurate diagnosis of AOM and otitis media with effusion.
Evolocumab lowers LDL in familial hypercholesterolemia
Evolocumab effectively lowered plasma LDL in patients with homozygous or severe heterozygous familial hypercholesterolemia, according to long-term data from the TAUSSIG trial published in the Journal of the American College of Cardiology.